Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonlicromanol in pediatric genetically confirmed mitochondrial disease
2020-003124-16Phase 2Terminated
- Sponsor
- Khondrion
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Mitochondriopathy comparing Sonlicromanol with Placebo (2 arms). Primary endpoint: Change in motor function (GMFM-88). Started Oct 2020; status: terminated.
02
Drugs
sonlicromanol
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on 2020-003124-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003124-16.